Coronado Biosciences Inc. (NASDAQ:CNDO) opened at $3.07 and after falling by 9.54% it closed at $2.75. The intraday range of the stock was $2.70 – $3.15, while its 52-week trading range is of $1.25 and $12.70. At its previous closing, the stock was down about 78.35% from its 52-week high and up by 120.00% from its 52-week low. The company traded with approximately, 4.90 million shares during the session. And its average trading volume remained 2.41 million shares. The company has market capitalization of $93.35 million with 33.94 million shares outstanding. Coronado Biosciences Inc (NASDAQ:CNDO) stock in last trading day opened at $3.07, traded the day range of $2.70 – $3.15, and closed at $2.75. The stock showed a negative performance of -9.54% in previous trading session.
Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) opened at $5.71 and after falling by 5.80% it closed at $5.36. The intraday range of the stock was $5.33 – $5.82, while its 52-week trading range is of $2.53 and $6.47. At its previous closing, the stock was down about 17.16% from its 52-week high and up by 111.86% from its 52-week low. The company traded with approximately, 1.06 million shares during the session. And its average trading volume remained 0.854 million shares. The company has market capitalization of $326.02 million with 60.83 million shares outstanding. In last trading activity, Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) traded 60.83 million shares and the average volume of the stock was recorded as 854,477.00 shares. The 52 week range of the stock is $5.33 – $5.82. The stock was dropped -5.80% by closing at $5.36.
XOMA Corp (NASDAQ:XOMA) opened its last trade at the price of $7.10. Its closing price was $7.30 after gaining 3.25% for the day. The company average trading volume remained 2.21 million shares. The beta of this stock stands at 2.39. XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. The company offers ACEON, an angiotensin converting enzyme inhibitor. XOMA Corp (NASDAQ:XOMA) stock on December 27, 2013, recorded a fall of -5.34% and was in a range of $6.75 – $7.33 before closing at $6.91. Company’s 52-week low price is $2.37and 52 week high price is $7.45.
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) was troubled last month when Food and Drug Administration called for the sale stop of its leukemia drug in the U.S. This was a hurting move considering that the company had already adjusted its operations and hired more staff to support the production and sale of the drug which is called Iclusig.Ariad Pharmaceuticals, Inc.(NASDAQ:ARIA) shares fell -5.14% in last trading session and was closed at $6.64, while trading in range of $6.51 – $6.92. Its return on equity ratio is recorded as -100.20% and its return on assets is -70.60%.
Geron Corporation (NASDAQ:GERN) showed a volume of 10.11 million shares by the end of last trade whereas the average volume of the stock remained 6.87 million shares. The stock opened the session at $4.76but then moved to $4.84. At that price, the stock showed a positive performance of 1.79%.Geron Corporation (NASDAQ:GERN) stock in last trading day opened at $5.08, traded the day range of $4.83 – $5.08, and closed at $4.84. The stock showed a negative performance of -5.10% in previous trading session.
Leave a Reply